ThermoGenesis Holdings Inc
NASDAQ:THMO 2:38:20 PM EDT
| Market Cap (Intraday) | 2.04M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 8.13 |
| 10-Day MA | $0.75 |
| 50-Day MA | $0.82 |
| 200-Day MA | $0.96 |
ThermoGenesis Holdings Inc Stock, NASDAQ:THMO
2711 Citrus Road, Rancho Cordova, California 95742
United States of America
Phone: +1.916.858.5100
Number of Employees: 25
Description
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.